Three-year safety observation of subcutaneous administration of epoetin-zeta in patients with chronic renal anemia: Results from PASCO II study
Sign Up to like & getrecommendations! Published in 2023 at "Clinical Nephrology"
DOI: 10.5414/cn110825
Abstract: Epoetin has been used to treat patients with renal anemia since 1988. Anti-erythropoietin antibody-mediated pure red cell aplasia (PRCA) has been associated with epoetin usage, and a PRCA incidence of 4.5 per 10,000 patient-years was… read more here.
Keywords: epoetin; safety; renal anemia; pasco study ... See more keywords